A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Agulnik, M; Costa, RLB; Milhem, M; Rademaker, AW; Prunder, BC; Daniels, D; Rhodes, BT; Humphreys, C; Abbinanti, S; Nye, L; Cehic, R; Polish, A; Vintilescu, C; McFarland, T; Skubitz, K; Robinson, S; Okuno, S; Van Tine, BA

Agulnik, M (reprint author), Northwestern Univ, Div Hematol Oncol, 676 North St Claire St,Suite 850, Chicago, IL 60610 USA.

ANNALS OF ONCOLOGY, 2017; 28 (1): 121

Abstract

Background: Soft tissue sarcomas (STSs) overexpress vascular endothelial growth factors (VEGF) and VEGF-receptors (VEGFR) activation have been associa......

Full Text Link